P-254 Cardiac and hidden toxicity of carfilzomib in presence of cardiometabolic syndrome and early-stage heart failure with reduced ejection fraction

Panagiotis Efentakis; Aimilia Varela; Sofia Lamprou; Eleni‐Dimitra Papanagnou; Michail Chatzistefanou; Andriana Christodoulou; Constantinos H. Davos; Maria Gavriatopoulou; Ioannis P. Trougakos; Meletios A Dimopoulos; Ioanna Andreadou; Evangelos Terpos

doi:10.1016/s2152-2650(23)01872-4

Related publications

Article2024

Implications and hidden toxicity of cardiometabolic syndrome and early‐stage heart failure in carfilzomib‐induced cardiotoxicity

Panagiotis Efentakis, Aimilia Varela, Sofia Lamprou, Eleni‐Dimitra Papanagnou, Michail Chatzistefanou, Andriana Christodoulou, Constantinos H. Davos, Maria Gavriatopoulou, Ioannis P. Trougakos, Meletios A Dimopoulos, Evangelos Terpos, Ioanna Andreadou

Article2017

Heart failure with reduced ejection fraction

Michelle Bloom, Barry Greenberg, Tiny Jaarsma, James L. Januzzi, Carolyn S.P. Lam, Aldo Maggioni, Jean‐Noël Trochu, Javed Butler

Article2020

Risk stratification in heart failure with mild reduced ejection fraction

Damiano Magrì, Giovanna Gallo, Gianfranco Parati, Mariantonietta Cicoira, Michele Senni

Article2019

Pulse pressure and prognosis in patients with heart failure with reduced ejection fraction

Neeraj Shah, Min Qian, Marco R. Di Tullio, Susan Graham, Douglas L. Mann, Ralph L. Sacco, Professor Gregory Lip, Arthur J. Labovitz, Piotr Ponikowski, Dirk J. Lok, Stefan D. Anker, John R. Teerlink, John L.P. Thompson, Shunichi Homma, Ronald S. Freudenberger

Article2011

Cardiac Dysfunction and Noncardiac Dysfunction as Precursors of Heart Failure With Reduced and Preserved Ejection Fraction in the Community

Carolyn S.P. Lam, Asya Lyass, Elisabeth Kraigher‐Krainer, Joseph M. Massaro, Douglas S. Lee, Jennifer E. Ho, Daniel Levy, Margaret M. Redfield, Burkert Pieske, Emelia Benjamin, Ramachandran S. Vasan